Status:
COMPLETED
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
Lead Sponsor:
Fundacion GESICA
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Despite formal recommendations, evidence of efficacy of aspirin in individuals with diabetes is scant and controversial. While the efficacy of aspirin versus placebo in patients with diabetes is curre...
Detailed Description
Despite the very high cardiovascular risk profile, evidence of efficacy of aspirin in individuals with diabetes is scant. The meta-analysis on the efficacy of antiplatelet therapy involving a total o...
Eligibility Criteria
Inclusion
- Diabetes mellitus treated with insulin or orl agents
- At least 50 years old
Exclusion
- Previous cardiovascular events
- current or past (within last 30 days) treatment with aspirin
- current or past (within last 180 days) treatment with statins
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00793754
Start Date
March 1 2009
End Date
October 1 2011
Last Update
October 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Educación Médica e Investigaciones Clínicas (CEMIC)
Buenos Aires, Argentina